Christine MH-UK
12-17-2007, 06:08 AM
What I found interesting was that they mentioned that herceptin saves by reducing the costs of metastatic care, since I was sure I had read this before but couldn't remember where, so now at least I have a source for this.
Cost-effectiveness analysis of trastuzumab therapy in patients with early HER-2 positive breast cancer in Brazil.
http://www.abstracts2view.com/sabcs/view.php?nu=SABCS07L_358&terms=
This was based on the HERA trial
Cost-effectiveness analysis of trastuzumab therapy in patients with early HER-2 positive breast cancer in Brazil.
http://www.abstracts2view.com/sabcs/view.php?nu=SABCS07L_358&terms=
This was based on the HERA trial